• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>ISRN Hypertension >The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
【24h】

The Second Canadian Symposium on Hepatitis C Virus: A Call to Action

机译：第二届加拿大丙型肝炎病毒研讨会：行动呼吁

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In Canada, hepatitis C virus (HCV) infection results in considerable morbidity, mortality and health-related costs. Within the next three to 10 years, it is expected that tolerable, short-duration (12 to 24 weeks) therapies capable of curing >90% of those who undergo treatment will be approved. Given that most of those already infected are aging and at risk for progressive liver disease, building research-based interdisciplinary prevention, care and treatment capacity is an urgent priority. In an effort to increase the dissemination of knowledge in Canada in this rapidly advancing field, the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) established an annual interdisciplinary Canadian Symposium on Hepatitis C Virus. The first symposium was held in Montreal, Quebec, in 2012, and the second symposium was held in Victoria, British Columbia, in 2013. The current article presents highlights from the 2013 meeting. It summarizes recent advances in HCV research in Canada and internationally, and presents the consensus of the meeting participants that Canada would benefit from having its own national HCV strategy to identify critical gaps in policies and programs to more effectively address the challenges of expanding HCV screening and treatment.
机译：在加拿大，丙型肝炎病毒（HCV）感染导致较高的发病率，死亡率和与健康相关的成本。在接下来的三到十年内，有望批准能够治愈超过90％接受治疗的患者的耐受性，短期（12至24周）疗法。鉴于大多数已被感染的人正在衰老并有进行性肝病的风险，建立基于研究的跨学科预防，护理和治疗能力是当务之急。为了增加在这个迅速发展的领域中加拿大的知识传播，国家CIHR丙型肝炎研究培训计划（NCRTP-HepC）建立了加拿大年度丙型肝炎跨学科研讨会。第一次专题讨论会于2012年在魁北克蒙特利尔举行，第二次专题讨论会于2013年在不列颠哥伦比亚省的维多利亚举行。本文是2013年会议的重点。它总结了加拿大和国际上在HCV研究方面的最新进展，并提出了与会代表的共识，即加拿大将受益于拥有自己的国家HCV战略，以发现政策和计划中的重大差距，从而更有效地应对扩大HCV筛查和推广的挑战。治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号